News & Views
SeQuant Acquired in Strategic Move
Jun 13 2008
product portfolio.
âWe are pleased to have made this acquisition. It offers Merck superb
opportunities for the future expansion of the chromatography businessâ said Klaus Bischoff, Head of Performance & Life Science Chemicals division at Merck. âBy acquiring SeQuant we are gaining access to a unique technology in the rapidly growing HILIC application segment for analytical and preparative purposes. This technology will enable us to develop and commercialise innovative products that meet the needs of
our customers,â he added. Renamed Merck SeQuant AB, the previous site and all employees of the former company have been retained.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia